What a great day😉 Shareholders,
The Kontrol Technology Inc company wants to be recognized more than a covid product but rather than a technology company detecting various viruses for future as well. The life expectancy of the Biocloud is 10-12 years therefore the product will be able to adapt to the future which equals to recurring revenue which means share the way it's structured. The patient investors will be rewarded big time.
The financials are in two weeks which means revenue may be the same which is good. When the orders are released, these sales will be recorded in 3 months or next quarter and will definitely be higher which usually increases share value enough and we may have the magical numbers to be uplifted to another exchange which again will increase the share price. Then we look at another quarter and based on demands we will know if the numbers were greater than previous which they may be and again hate to sound like a broken record but tight share structure will raise the share price again.
This is is no brainer, you will all see and be proven once orders are released and investors will have more faith then ever.
Kokomak